219 related articles for article (PubMed ID: 26891731)
1. Impact of Prothrombotic Risk Factors in a Cohort of Egyptian Hemophilia A Patients.
El-Din Hamdy MS; Nasr AS; Makhlouf MM; El-Saadany ZA; Samir M; Morgan DS
Mol Diagn Ther; 2016 Apr; 20(2):151-9. PubMed ID: 26891731
[TBL] [Abstract][Full Text] [Related]
2. Effect of prothrombotic mutations on factor consumption in children with hemophilia.
Tüten H; Çam H; Özdemir N; Bezgal F; Buyru N; Zülfikar B; Celkan T
Clin Appl Thromb Hemost; 2013; 19(4):445-8. PubMed ID: 22411997
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
6. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
8. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
9. Clinical variability of haemophilia A and B in Mexican families by factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T/A1298C.
López-Jiménez JJ; Beltrán-Miranda CP; Mantilla-Capacho JM; Esparza-Flores MA; López González LC; Jaloma-Cruz AR
Haemophilia; 2009 Nov; 15(6):1342-5. PubMed ID: 19601986
[No Abstract] [Full Text] [Related]
10. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
11. Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.
El Sebay HM; Safan MA; Daoud AA; Tayel SI; Nouh MA; El Shafie S
J Gastroenterol Hepatol; 2016 Jan; 31(1):235-40. PubMed ID: 26238013
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilic genes alterations as risk factor for recurrent pregnancy loss.
Farahmand K; Totonchi M; Hashemi M; Reyhani Sabet F; Kalantari H; Gourabi H; Mohseni Meybodi A
J Matern Fetal Neonatal Med; 2016; 29(8):1269-73. PubMed ID: 26135458
[TBL] [Abstract][Full Text] [Related]
14. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.
Hussein AS
J Thromb Thrombolysis; 2012 Oct; 34(3):383-7. PubMed ID: 22528331
[TBL] [Abstract][Full Text] [Related]
17. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
18. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
[TBL] [Abstract][Full Text] [Related]
19. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
[TBL] [Abstract][Full Text] [Related]
20. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
